1,112
Views
11
CrossRef citations to date
0
Altmetric
Review Articles

Personalising transcranial magnetic stimulation for depression using neuroimaging: A systematic review

ORCID Icon &
Pages 647-669 | Received 02 Sep 2020, Accepted 28 Jan 2021, Published online: 21 Apr 2021

References

  • Arns M, Spronk D, Fitzgerald PB. 2010. Potential differential effects of 9 Hz rTMS and 10 Hz rTMS in the treatment of depression. Brain Stimul. 3(2):124–126.
  • Baeken C, De Raedt R, Leyman L, Schiettecatte J, Kaufman L, Poppe K, Vanderhasselt M, Anckaert E, Bossuyt A. 2009. The impact of one HF-rTMS session on mood and salivary cortisol in treatment resistant unipolar melancholic depressed patients. J Affect Disord. 113(1–2):100–108.
  • Baeken C, Marinazzo D, Everaert H, Wu G-R, Van Hove C, Audenaert K, Goethals I, De Vos F, Peremans K, De Raedt R. 2015. The impact of accelerated HF-rTMS on the subgenual anterior cingulate cortex in refractory unipolar major depression: insights from 18FDG PET brain imaging. Brain Stimul. 8(4):808–815.
  • Beam W, Borckardt JJ, Reeves ST, George MS. 2009. An efficient and accurate new method for locating the F3 position for prefrontal TMS applications. Brain Stimul. 2(1):50–54.
  • Blumberger DM, Maller JJ, Thomson L, Mulsant BH, Rajji TK, Maher M, Brown PE, Downar J, Vila-Rodriguez F, Fitzgerald PB, et al. 2016. Unilateral and bilateral MRI-targeted repetitive transcranial magnetic stimulation for treatment-resistant depression: a randomized controlled study. J Psychiatry Neurosci. 41(4):E58–E66.
  • Blumberger DM, Vila-Rodriguez F, Thorpe KE, Feffer K, Noda Y, Giacobbe P, Knyahnytska Y, Kennedy SH, Lam RW, Daskalakis ZJ, et al. 2018. Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial. Lancet. 391(10131):1683–1692.
  • Chen L, Chung SW, Hoy KE, Fitzgerald PB. 2019. Is theta burst stimulation ready as a clinical treatment for depression? Expert Rev Neurother. 19(11):1089–1102.
  • Cocchi L, Zalesky A. 2018. Personalized transcranial magnetic stimulation in psychiatry. Biol Psychiatry Cogn Neurosci Neuroimaging. 3(9):731–741.
  • Cole EJ, Stimpson KH, Bentzley BS, Gulser M, Cherian K, Tischler C, Nejad R, Pankow H, Choi E, Aaron H, et al. 2020. Stanford accelerated intelligent neuromodulation therapy for treatment-resistant depression [Brain Imaging; Empirical Study; Quantitative Study]. Am J Psychiatry. 177(8):716–726.
  • Dell’Osso B, Mundo E, D’Urso N, Pozzoli S, Buoli M, Ciabatti M, Rosanova M, Massimini M, Bellina V, Mariotti M, et al. 2009. Augmentative repetitive navigated transcranial magnetic stimulation (rTMS) in drug-resistant bipolar depression. Bipolar Disorders. 11(1):76–81.
  • Downar J, Geraci J, Salomons TV, Dunlop K, Wheeler S, McAndrews MP, Bakker N, Blumberger DM, Daskalakis ZJ, Kennedy SH, et al. 2014. Anhedonia and reward-circuit connectivity distinguish nonresponders from responders to dorsomedial prefrontal repetitive transcranial magnetic stimulation in major depression. Biol Psychiatry. 76(3):176–185.
  • Duprat R, Desmyter S, Rudi DR, van Heeringen K, Van den Abbeele D, Tandt H, Bakic J, Pourtois G, Dedoncker J, Vervaet M, et al. 2016. Accelerated intermittent theta burst stimulation treatment in medication-resistant major depression: a fast road to remission? J Affect Disord. 200:6–14.
  • Eshel N, Keller CJ, Wu W, Jiang J, Mills-Finnerty C, Huemer J, Wright R, Fonzo GA, Ichikawa N, Carreon D, et al. 2020. Global connectivity and local excitability changes underlie antidepressant effects of repetitive transcranial magnetic stimulation. Neuropsychopharmacology. 45(6):1018–1025.
  • Etkin A. 2016–2022. Brain-based biomarkers in response to TMS in MDD. ClinicalTrials.gov Identifier: NCT02843373. National Institute of Health, U.S National Library of Medicine; [accessed 2020 Dec 13]. https://clinicaltrials.gov/ct2/show/NCT02843373.
  • Fitzgerald PB, Hoy K, McQueen S, Maller JJ, Herring S, Segrave R, Bailey M, Been G, Kulkarni J, Daskalakis ZJ. 2009. A randomized trial of rTMS targeted with MRI based neuro-navigation in treatment-resistant depression. Neuropsychopharmacology. 34(5):1255–1262.
  • Fox MD, Buckner RL, White MP, Greicius MD, Pascual-Leone A. 2012. Efficacy of transcranial magnetic stimulation targets for depression is related to intrinsic functional connectivity with the subgenual cingulate. Biol Psychiatry. 72(7):595–603.
  • George MS, Lisanby SH, Avery D, McDonald WM, Durkalski V, Pavlicova M, Anderson B, Nahas Z, Bulow P, Zarkowski P, et al. 2010. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry. 67(5):507–516.
  • George MS, Wassermann EM, Williams WA, Callahan A, Ketter TA, Basser P, Hallett M, Post RM. 1995. Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. Neuroreport. 6(14):1853–1856.
  • Hayasaka S, Nakamura M, Noda Y, Izuno T, Saeki T, Iwanari H, Hirayasu Y. 2017. Lateralized hippocampal volume increase following high-frequency left prefrontal repetitive transcranial magnetic stimulation in patients with major depression. Psychiatry Clin Neurosci. 71(11):747–758.
  • Herwig U, Lampe Y, Juengling FD, Wunderlich A, Walter H, Spitzer M, Schonfeldt-Lecuona C. 2003. Add-on rTMS for treatment of depression: a pilot study using stereotaxic coil-navigation according to PET data. J Psychiatr Res. 37(4):267–275.
  • Herwig U, Padberg F, Unger J, Spitzer M, Schonfeldt-Lecuona C. 2001. Transcranial magnetic stimulation in therapy studies: examination of the reliability of “standard” coil positioning by neuronavigation. Biol Psychiatry. 50(1):58–61.
  • Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). 2020. Cochrane handbook for systematic reviews of interventions version 6.1 (updated September 2020). Cochrane; [accessed 2020 Apr 7]. www.training.cochrane.org/handbook.
  • Hsu WY, Kuo YF, Liao KK, Yu HY, Lin YY. 2015. Widespread inter-ictal excitability changes in patients with temporal lobe epilepsy: a TMS/MEG study. Epilepsy Res. 111:61–71.
  • Hung YY, Yang LH, Stubbs B, Li DJ, Tseng PT, Yeh TC, Chen TY, Liang CS, Chu CS. 2020. Efficacy and tolerability of deep transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 99:109850.
  • Iwabuchi S, Auer D, Lankappa S, Palaniyappan L. 2019. Baseline effective connectivity predicts response to repetitive transcranial magnetic stimulation in patients with treatment-resistant depression. Eur Neuropsychopharmacol. 29(5):681–690.
  • Jalinous R. 1991. Technical and practical aspects of magnetic nerve stimulation. J Clin Neurophysiol. 8(1):10–25.
  • Jha S, Chadda RK, Kumar N, Bal C. 2016. Brain SPECT guided repetitive transcranial magnetic stimulation (rTMS) in treatment resistant major depressive disorder. Asian J Psychiatr. 21:1–6.
  • Jin Y, Phillips B. 2014. A pilot study of the use of EEG-based synchronized Transcranial Magnetic Stimulation (sTMS) for treatment of major depression. BMC Psychiatry. 14:13.
  • Leuchter AF, Cook IA, Feifel D, Goethe JW, Husain M, Carpenter LL, Thase ME, Krystal AD, Philip NS, Bhati MT, et al. 2015. Efficacy and safety of low-field synchronized Transcranial Magnetic Stimulation (sTMS) for treatment of major depression. Brain Stimul. 8(4):787–794.
  • Liu B, Zhang Y, Zhang L, Li L. 2014. Repetitive transcranial magnetic stimulation as an augmentative strategy for treatment-resistant depression, a meta-analysis of randomized, double-blind and sham-controlled study. BMC Psychiatry. 14(1):342.
  • Makela JP, Lioumis P, Laaksonen K, Forss N, Tatlisumak T, Kaste M, Mustanoja S. 2015. Cortical excitability measured with nTMS and MEG during stroke recovery. Neural Plast. 2015:309546.
  • Martinot M-LP, Galinowski A, Ringuenet D, Gallarda T, Lefaucheur J-P, Bellivier F, Picq C, Bruguiere P, Mangin J-F, Riviere D, et al. 2010. Influence of prefrontal target region on the efficacy of repetitive transcranial magnetic stimulation in patients with medication-resistant depression: a [(18)F]-fluorodeoxyglucose PET and MRI study. Int J Neuropsychopharmacol. 13(1):45–59.
  • McClintock SM, Reti IM, Carpenter LL, McDonald WM, Dubin M, Taylor SF, Cook IA, O’Reardon J, Husain MM, Wall C, et al. 2018. Consensus recommendations for the clinical application of Repetitive Transcranial Magnetic Stimulation (rTMS) in the treatment of depression. J Clin Psychiatry. 79(1):16cs10905.
  • Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. 2009. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 6(7):e1000097.
  • Neacsiu AD, Luber BM, Davis SW, Bernhardt E, Strauman TJ, Lisanby SH. 2018. On the concurrent use of self-system therapy and functional magnetic resonance imaging-guided transcranial magnetic stimulation as treatment for depression. J Ect. 34(4):266–273.
  • Nguyen TD, Hieronymus F, Lorentzen R, McGirr A, Ostergaard SD. 2021. The efficacy of repetitive transcranial magnetic stimulation (rTMS) for bipolar depression: a systematic review and meta-analysis. J Affect Disord. 279:250–255.
  • Pan F, Shen Z, Jiao J, Chen J, Li S, Lu J, Duan J, Wei N, Shang D, Hu S, et al. 2020. Neuronavigation-guided rTMS for the treatment of depressive patients with suicidal ideation: a double-blind, randomized, sham-controlled trial. Clin Pharmacol Ther. 108(4):826–832.
  • Patel V, Chisholm D, Parikh R, Charlson FJ, Degenhardt L, Dua T, Ferrari AJ, Hyman S, Laxminarayan R, Levin C, et al. 2016. Addressing the burden of mental, neurological, and substance use disorders: key messages from Disease Control Priorities, 3rd edition. Lancet. 387(10028):1672–1685.
  • Pellicciari MC, Ponzo V, Caltagirone C, Koch G. 2017. Restored asymmetry of prefrontal cortical oscillatory activity after bilateral theta burst stimulation treatment in a patient with major depressive disorder: a TMS-EEG study. Brain Stimul. 10(1):147–149.
  • Persson J, Struckmann W, Gingnell M, Fallmar D, Boden R. 2020. Intermittent theta burst stimulation over the dorsomedial prefrontal cortex modulates resting-state connectivity in depressive patients: a sham-controlled study. Behav Brain Res. 394:112834.
  • Philip NS, Aiken EE, Kelley ME, Burch W, Waterman L, Holtzheimer PE. 2019. Synchronized transcranial magnetic stimulation for posttraumatic stress disorder and comorbid major depression. Brain Stimul. 12(5):1335–1337.
  • Pompili M, Innamorati M, Lamis DA, Erbuto D, Venturini P, Ricci F, Serafini G, Amore M, Girardi P. 2014. The associations among childhood maltreatment, “male depression” and suicide risk in psychiatric patients. Psychiatry Res. 220(1–2):571–578.
  • Poydasheva AG, Sinitsyn DO, Bakulin IS, Suponeva NA, Maslennikov NV, Tsukarzi EE, Mosolov SN, Piradov MA. 2019. Target determination for transcranial magnetic stimulation in patients with a pharmacotherapy-resistant depressive episode based on the individual parameters of resting-state functional magnetic resonance imaging (a pilot blind controlled trial). RJTAO. 11(4):44–50.
  • Price GW, Lee JW, Garvey C-AL, Gibson N. 2010. The use of background EEG activity to determine stimulus timing as a means of improving rTMS efficacy in the treatment of depression: a controlled comparison with standard techniques. Brain Stimul. 3(3):140–152.
  • Rajkowska G, Goldman-Rakic PS. 1995. Cytoarchitectonic definition of prefrontal areas in the normal human cortex: II. variability in locations of areas 9 and 46 and relationship to the Talairach Coordinate System. Cereb Cortex. 5(4):323–337.
  • Rogasch NC, Fitzgerald PB. 2013. Assessing cortical network properties using TMS-EEG. Hum Brain Mapp. 34(7):1652–1669.
  • Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, Niederehe G, Thase ME, Lavori PW, Lebowitz BD, et al. 2006. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 163(11):1905–1917.
  • Rusjan PM, Barr MS, Farzan F, Arenovich T, Maller JJ, Fitzgerald PB, Daskalakis ZJ. 2010. Optimal transcranial magnetic stimulation coil placement for targeting the dorsolateral prefrontal cortex using novel magnetic resonance image-guided neuronavigation. Hum Brain Mapp. 31(11):1643–1652.
  • Saeki T, Nakamura M, Hirai N, Noda Y, Hayasaka S, Iwanari H, Hirayasu Y. 2013. Localized potentiation of sleep slow-wave activity induced by prefrontal repetitive transcranial magnetic stimulation in patients with a major depressive episode. Brain Stimul. 6(3):390–396.
  • Sehatzadeh S, Daskalakis ZJ, Yap B, Tu H-A, Palimaka S, Bowen JM, O’Reilly DJ. 2019. Unilateral and bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression: a meta-analysis of randomized controlled trials over 2 decades. J Psychiatry Neurosci. 44(3):151–163.
  • Siddiqi SH, Trapp NT, Hacker CD, Laumann TO, Kandala S, Hong X, Trillo L, Shahim P, Leuthardt EC, Carter AR, et al. 2019. Repetitive transcranial magnetic stimulation with resting-state network targeting for treatment-resistant depression in traumatic brain injury: a randomized, controlled, double-blinded pilot study. J Neurotrauma. 36(8):1361–1374.
  • Stubbeman WF, Zarrabi B, Bastea S, Ragland V, Khairkhah R. 2018. Bilateral neuronavigated 20Hz theta burst TMS for treatment refractory depression: an open label study. Brain Stimul. 11(4):953–955.
  • Tang N, Jin Y, Zhan S-Y, Huang Y-Q. 2010. Magnetic neuro-EEG synchronization therapy for nonresponders to medication for depression: a multi-center randomized, double-blind, sham-controlled trial. Chin Mental Health J. 24(6):435–439.
  • Thase ME, Rush AJ. 1997. When at first you don’t succeed: sequential strategies for antidepressant nonresponders. J Clin Psychiatry. 58 (Suppl 13):23–29.
  • Trojak B, Meille V, Chauvet-Gelinier JC, Bonin B. 2011. Further evidence of the usefulness of MRI-based neuronavigation for the treatment of depression by rTMS. J Neuropsychiatry Clin Neurosci. 23(2):E30–E31.
  • Trojak B, Meille V, Jonval L, Schuffenecker N, Haffen E, Schwan R, Bonin B, Chauvet-Gelinier J-C. 2014. Interest of targeting either cortical area Brodmann 9 or 46 in rTMS treatment for depression: a preliminary randomized study. Clin Neurophysiol. 125(12):2384–2389.
  • Wall CA, Croarkin PE, Maroney-Smith MJ, Haugen LM, Baruth JM, Frye MA, Sampson SM, Port JD. 2016. Magnetic resonance imaging-guided, open-label, high-frequency repetitive transcranial magnetic stimulation for adolescents with major depressive disorder. J Child Adolesc Psychopharmacol. 26(7):582–589.
  • Williams NR, Sudheimer KD, Bentzley BS, Pannu J, Stimpson KH, Duvio D, Cherian K, Hawkins J, Scherrer KH, Vyssoki B, et al. 2018. High-dose spaced theta-burst TMS as a rapid-acting antidepressant in highly refractory depression. Brain. 141(3):e18.
  • Woźniak-Kwaśniewska A, Szekely D, Harquel S, Bougerol T, David O. 2015. Resting electroencephalographic correlates of the clinical response to repetitive transcranial magnetic stimulation: a preliminary comparison between unipolar and bipolar depression. J Affect Disord. 183:15–21.
  • Wu W, Keller CJ, Rogasch NC, Longwell P, Shpigel E, Rolle CE, Etkin A. 2018. ARTIST: a fully automated artifact rejection algorithm for single-pulse TMS-EEG data. Hum Brain Mapp. 39(4):1607–1625.
  • Zhang Z, Zhang H, Xie CM, Zhang M, Shi Y, Song R, Lu X, Zhang H, Li K, Wang B. 2020. Task-related functional magnetic resonance imaging-based neuronavigation for the treatment of depression by individualized repetitive transcranial magnetic stimulation of the visual cortex. Sci China Life Sci. 64(1):96–106.
  • Zrenner B, Zrenner C, Gordon PC, Belardinelli P, McDermott EJ, Soekadar SR, Fallgatter AJ, Ziemann U, Muller-Dahlhaus F. 2019. Brain oscillation-synchronized stimulation of the left dorsolateral prefrontal cortex in depression using real-time EEG-triggered TMS. Brain Stimul. 13(1):197–205.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.